{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:22:10Z","timestamp":1772176930218,"version":"3.50.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8,1]]},"DOI":"10.1215\/15228517-2008-107","type":"journal-article","created":{"date-parts":[[2009,3,17]],"date-time":"2009-03-17T00:45:16Z","timestamp":1237250716000},"page":"430-436","source":"Crossref","is-referenced-by-count":56,"title":["Pseudoprogression in boron neutron capture therapy for malignant gliomas and meningiomas"],"prefix":"10.1093","volume":"11","author":[{"given":"Shin-Ichi","family":"Miyatake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naosuke","family":"Nonoguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Kuroiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,8,1]]},"reference":[{"key":"key\n\t\t\t\t20171012050548_REF1","doi-asserted-by":"crossref","unstructured":"Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352: 987-996.","DOI":"10.1056\/NEJMoa043330"},{"key":"key\n\t\t\t\t20171012050548_REF2","doi-asserted-by":"crossref","unstructured":"Chamberlain MC, Glantz MJ, Chalmers L, Van Horn A, Sloan AE. Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. J Neurooncol. 2007;82: 81-83.","DOI":"10.1007\/s11060-006-9241-y"},{"key":"key\n\t\t\t\t20171012050548_REF3","doi-asserted-by":"crossref","unstructured":"Taal W, Brandsma D, de Bruin HG, et al. Incidence of early pseudoprogression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide. Cancer. 2008;113(2): 405-410.","DOI":"10.1002\/cncr.23562"},{"key":"key\n\t\t\t\t20171012050548_REF4","doi-asserted-by":"crossref","unstructured":"Kawabata S, Miyatake S, Kajimoto Y, et al. The early successful treatment of glioblastoma patients with modified boron neutron capture therapy. Report of two cases. J Neurooncol. 2003;65: 159-165.","DOI":"10.1023\/B:NEON.0000003751.67562.8e"},{"key":"key\n\t\t\t\t20171012050548_REF5","doi-asserted-by":"crossref","unstructured":"Miyatake S, Kawabata S, Kajimoto Y, et al. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: An efficacy study based on findings on neuroimages. J Neurosurg. 2005;103: 1000-1009.","DOI":"10.3171\/jns.2005.103.6.1000"},{"key":"key\n\t\t\t\t20171012050548_REF6","doi-asserted-by":"crossref","unstructured":"Miyatake S, Tamura Y, Kawabata S, Iida K, Kuroiwa T, Ono K. Boron neutron capture therapy for malignant tumors related to meningiomas. Neurosurgery. 2007;61: 82-91.","DOI":"10.1227\/01.neu.0000279727.90650.24"},{"key":"key\n\t\t\t\t20171012050548_REF7","doi-asserted-by":"crossref","unstructured":"Tamura Y, Miyatake S, Nonoguchi N, et al. Boron neutron capture therapy for recurrent malignant meningioma. Case report. J Neurosurg. 2006;105: 898-903.","DOI":"10.3171\/jns.2006.105.6.898"},{"key":"key\n\t\t\t\t20171012050548_REF8","doi-asserted-by":"crossref","unstructured":"Coderre JA, Chanana AD, Joel DD, et al. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: Boron concentration correlates with tumor cellularity. Radiat Res. 1998;149: 163-170.","DOI":"10.2307\/3579926"},{"key":"key\n\t\t\t\t20171012050548_REF9","doi-asserted-by":"crossref","unstructured":"Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984;133: 1710-1715.","DOI":"10.4049\/jimmunol.133.4.1710"},{"key":"key\n\t\t\t\t20171012050548_REF10","unstructured":"Imahori Y, Ueda S, Ohmori Y, et al. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: Part I. Clin Cancer Res. 1998;4: 1825-1832."},{"key":"key\n\t\t\t\t20171012050548_REF11","unstructured":"Imahori Y, Ueda S, Ohmori Y, et al. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: Part II. Clin Cancer Res. 1998;4: 1833-1841."},{"key":"key\n\t\t\t\t20171012050548_REF12","doi-asserted-by":"crossref","unstructured":"Ishiwata K, Ido T, Mejia AA, Ichihashi M, Mishima Y. Synthesis and radiation dosimetry of 4-borono-2-[18F]fluoro-D,L-phenylalanine: A target compound for PET and boron neutron capture therapy. Int J Rad Appl Instrum A. 1991;42: 325-328.","DOI":"10.1016\/0883-2889(91)90133-L"},{"key":"key\n\t\t\t\t20171012050548_REF13","doi-asserted-by":"crossref","unstructured":"Mishima Y, Imahori Y, Honda C, Hiratsuka J, Ueda S, Ido T. In vivo diagnosis of human malignant melanoma with positron emission tomography using specific melanoma-seeking 18F-DOPA analogue. J Neurooncol. 1997;33: 163-169.","DOI":"10.1023\/A:1005746020350"},{"key":"key\n\t\t\t\t20171012050548_REF14","unstructured":"Imahori Y, Ueda S, Ohmori Y, et al. Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma. J Nucl Med. 1998;39: 325-333."},{"key":"key\n\t\t\t\t20171012050548_REF15","unstructured":"Takahashi Y, Imahori Y, Mineura K. Prognostic and therapeutic indicator of fluoroboronophenylalanine positron emission tomography in patients with gliomas. Clin Cancer Res. 2003;9: 5888-5895."},{"key":"key\n\t\t\t\t20171012050548_REF16","doi-asserted-by":"crossref","unstructured":"Kawabata S, Miyatake S, Kuroiwa T, et al. Boron neutron capture therapy for newly diagnosed glioblastoma. J Rad Res. In press.","DOI":"10.1269\/jrr.08043"},{"key":"key\n\t\t\t\t20171012050548_REF17","doi-asserted-by":"crossref","unstructured":"de Wit MC, de Bruin HG, Eijkenboom W, Sillevis Smitt PA, van den Bent MJ. Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression. Neurology. 2004;63: 535-537.","DOI":"10.1212\/01.WNL.0000133398.11870.9A"},{"key":"key\n\t\t\t\t20171012050548_","doi-asserted-by":"crossref","unstructured":"Fiegler W, Langer M, Scheer M, Kazner E. Reversible computed tomographic changes following brain tumor irradiation induced by the \u201cearly-delayed reaction\u201d after radiation [in German]. Der Radiologe. 1986;26: 206-209.","DOI":"10.1002\/mpo.2950190307"},{"key":"key\n\t\t\t\t20171012050548_","doi-asserted-by":"crossref","unstructured":"Griebel M, Friedman HS, Halperin EC, et al. Reversible neurotoxicity following hyperfractionated radiation therapy of brain stem glioma. Medical Pediatr Oncol. 1991;19: 182-186.","DOI":"10.1002\/mpo.2950190307"},{"key":"key\n\t\t\t\t20171012050548_REF20","doi-asserted-by":"crossref","unstructured":"Watne K, Hager B, Heier M, Hirschberg H. Reversible oedema and necrosis after irradiation of the brain. Diagnostic procedures and clinical manifestations. Acta Oncol. 1990;29: 891-895.","DOI":"10.3109\/02841869009096385"},{"key":"key\n\t\t\t\t20171012050548_REF21","doi-asserted-by":"crossref","unstructured":"Perry A, Schmidt RE. Cancer therapy-associated CNS neuropathology: An update and review of the literature. Acta Neuropathol. 2006;111: 197-212.","DOI":"10.1007\/s00401-005-0023-y"},{"key":"key\n\t\t\t\t20171012050548_REF22","doi-asserted-by":"crossref","unstructured":"Miyashita M, Miyatake S, Imahori Y, et al. Evaluation of fluoride-labeled boronophenylalanine-PET imaging for the study of radiation effects in patients with glioblastomas. J Neurooncol. 2008;89: 239-246.","DOI":"10.1007\/s11060-008-9621-6"},{"key":"key\n\t\t\t\t20171012050548_REF23","unstructured":"Ceyssens S, Van Laere K, de Groot T, Goffin J, Bormans G, Mortelmans L. [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence. AJNR Am J Neuroradiol. 2006;27: 1432-1437."},{"key":"key\n\t\t\t\t20171012050548_REF24","doi-asserted-by":"crossref","unstructured":"Tsuyuguchi N, Takami T, Sunada I, et al. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery\u2014in malignant glioma. Ann Nucl Med. 2004;18: 291-296.","DOI":"10.1007\/BF02984466"},{"key":"key\n\t\t\t\t20171012050548_REF25","doi-asserted-by":"crossref","unstructured":"Bauman GS, Sneed PK, Wara WM, et al. Reirradiation of primary CNS tumors. Int J Radiat Oncol Biol Phys. 1996;36: 433-441.","DOI":"10.1016\/S0360-3016(96)00315-X"},{"key":"key\n\t\t\t\t20171012050548_REF26","doi-asserted-by":"crossref","unstructured":"Mayer R, Sminia P. Reirradiation tolerance of the human brain. Int J Radiat Oncol Biol Phys. 2008;70: 1350-1360.","DOI":"10.1016\/j.ijrobp.2007.08.015"},{"key":"key\n\t\t\t\t20171012050548_REF27","doi-asserted-by":"crossref","unstructured":"Brandes AA, Franceschi E, Tosoni A, et al. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol. 2008;26: 2192-2197.","DOI":"10.1200\/JCO.2007.14.8163"},{"key":"key\n\t\t\t\t20171012050548_REF28","doi-asserted-by":"crossref","unstructured":"Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol. 2008;9: 453-461.","DOI":"10.1016\/S1470-2045(08)70125-6"},{"key":"key\n\t\t\t\t20171012050548_REF29","doi-asserted-by":"crossref","unstructured":"Wong CS, Van der Kogel AJ. Mechanisms of radiation injury to the central nervous system: Implications for neuroprotection. Mol Interv. 2004;4: 273-284.","DOI":"10.1124\/mi.4.5.7"},{"key":"key\n\t\t\t\t20171012050548_REF30","doi-asserted-by":"crossref","unstructured":"Gonzalez J, Kumar AJ, Conrad CA, Levin VA. Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys. 2007;67: 323-326.","DOI":"10.1016\/j.ijrobp.2006.10.010"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/11\/4\/430\/13065435\/12_NO08-00183_Miyatake.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T13:24:53Z","timestamp":1684934693000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article\/11\/4\/430\/1002277\/Pseudoprogression-in-boron-neutron-capture-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,1]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,8,1]]},"published-print":{"date-parts":[[2009,8,1]]}},"URL":"https:\/\/doi.org\/10.1215\/15228517-2008-107","relation":{},"ISSN":["1523-5866","1522-8517"],"issn-type":[{"value":"1523-5866","type":"electronic"},{"value":"1522-8517","type":"print"}],"subject":[],"published-other":{"date-parts":[[2009,8]]},"published":{"date-parts":[[2009,8,1]]}}}